Glaxosmithkline Puerto Rico, Inc.Profit-sharing plan
GSK PUERTO RICO 401(K) PLAN · PHILADELPHIA, PA · plan year 2025
Peer grade: A · admin costs + employer contributions vs same-size plans · how grading works
Glaxosmithkline Puerto Rico, Inc. reported $4,258 in plan administrative expenses for 2025: 0.01% of average plan assets, lower than ~75% of peers. Employer contributions averaged $18,182 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 3 years on file its reported administrative ratio rose from 0.006% to 0.007%. The plan sits in the $50M–$250M size bracket, benchmarked here against 605 comparable plans and shown alongside other manufacturing employers. By assets it is the 673rd-largest of 3,651 plans among Pennsylvania employers on file, and the 2,717th of 13,661 in manufacturing. In 2025, the employer put in $1.24 for every $1.00 employees contributed themselves; active participation has shrunk from 18 to 16 since 2022.
Glaxosmithkline Puerto Rico, Inc.'s 2025 employer contribution ran above the $4,093 median for plans its size, placing it in the top quarter of its peers. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2025 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 660613421 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.